|
| Home : NORGINE B.V. and KOREA PHARMA CO., LTD. Enter Into Exclusive Licence Agreement for the Commercialisation of PLENVU® in the Republic of Korea |
|
Jan 03
2019 |
NORGINE B.V. and KOREA PHARMA CO., LTD. Enter Into Exclusive Licence Agreement for the Commercialisation of PLENVU® in the Republic of Korea |
|
AMSTERDAM and SEOUL, South Korea, January 3, 2019 /PRNewswire/ -- Norgine to receive a significant upfront payment and undisclosed sums in sales milestones along with double-digit percentage royalties Norgine retains full commercial rights to PLENVU® in all unlicensed countries NORGINE... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/norgine-b-v-and-korea-pharma-co-ltd-enter-into-exclusive-licence-agreement-for-the-commercialisation-of-plenvu-r-in-the-republic-of-korea-888171036.html |
| |
|
Related News
|
» Tru-Form Plastics to Showcase Thermoforming Expertise at MD&M West
» Gathering Hotspots of the Preparation Industry, In Step with the International Pharmaceutical Trends
|
|
|
